Efficacy of silodosin in benign prostatic hyperplasia with overactive bladder.
Phase of Trial: Phase III
Latest Information Update: 30 Jan 2016
At a glance
- Drugs Silodosin (Primary)
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Therapeutic Use
- 30 Jan 2016 Status changed from recruiting to completed as per results published in the International Journal of Urology
- 04 Sep 2012 Actual initiation date changed from Feb 2011 to Jan 2008, as reported by University Hospital Medical Information Network - Japan.
- 04 Sep 2012 Status changed from completed to recruiting as reported by University Hospital Medical Information Network - Japan.